Kangyuan Pharmaceutical (301281.SZ): Currently not involved in medical consultation business.

Gelonghui November 5th, Ke Yuan Pharmaceuticals (301281.SZ) stated on the investor interaction platform that the company is mainly engaged in the research and development, production, and sales of chemical raw materials and their formulation products, and currently does not involve medical consulting businesses.

Gelonghui FinanceNov 5, 2024 02:24 ET

Shandong Keyuan Pharmaceutical's (SZSE:301281) Weak Earnings May Only Reveal A Part Of The Whole Picture

Simply Wall StOct 31, 2024 20:02 ET

Optimistic Investors Push Shandong Keyuan Pharmaceutical Co., Ltd. (SZSE:301281) Shares Up 151% But Growth Is Lacking

Simply Wall StOct 25, 2024 18:43 ET

Keyuan Pharmaceutical: Report for the third quarter of 2024

SZSIOct 24, 2024 12:00 ET · Announcements

Ke Yuan Pharmaceuticals (301281.SZ) released its performance for the first three quarters, with a net income of 39.6831 million yuan, a year-on-year decrease of 40.38%.

Koyuan Pharmaceuticals (301281.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching 3....

Zhitong FinanceOct 24, 2024 05:23 ET

Jinan's former richest man's assets are being reorganized! Which other companies are expected to be acquired?

List of Expected Listed Companies for Mergers and Acquisitions.

Gelonghui FinanceOct 23, 2024 07:10 ET